NUP43 and chronic myelogenous leukemia, BCR-ABL1 positive: MiRNA-409-5p inhibits proliferative potential and cell cycle progression in child chronic myeloid leukemia (CML) by upregulation of NUP43 expression (Liu et al., 2019).